Cargando…
Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope
Botulinum neurotoxin type E (BoNT/E), the fastest acting toxin of all BoNTs, cleaves the 25 kDa synaptosomal-associated protein (SNAP-25) in motor neurons, leading to flaccid paralysis. The specific detection and quantification of the BoNT/E-cleaved SNAP-25 neoepitope can facilitate the development...
Autores principales: | Mechaly, Adva, Diamant, Eran, Alcalay, Ron, Ben David, Alon, Dor, Eyal, Torgeman, Amram, Barnea, Ada, Girshengorn, Meni, Levin, Lilach, Epstein, Eyal, Tennenhouse, Ariel, Fleishman, Sarel J., Zichel, Ran, Mazor, Ohad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944829/ https://www.ncbi.nlm.nih.gov/pubmed/35323195 http://dx.doi.org/10.3390/antib11010021 |
Ejemplares similares
-
Small Molecule Receptor Binding Inhibitors with In Vivo Efficacy against Botulinum Neurotoxin Serotypes A and E
por: Ben David, Alon, et al.
Publicado: (2021) -
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries
por: David, Alon Ben, et al.
Publicado: (2021) -
Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs
por: Diamant, Eran, et al.
Publicado: (2015) -
High Cell Density Cultivation Process for the Expression of Botulinum Neurotoxin a Receptor Binding Domain
por: Ben David, Alon, et al.
Publicado: (2022) -
A Rabbit Model for the Evaluation of Drugs for Treating the Chronic Phase of Botulism
por: Torgeman, Amram, et al.
Publicado: (2021)